Staging of esophageal carcinoma: Length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?

Journal of Surgical Oncology

Volumn 94, Issue 5, 2006, Pages 355-363

  Bollschweiler, Elfriede ^a   Baldus, Stephan E ^a   Schröder, Wolfgang ^a   Schneider, Paul M ^a   Hölscher, Arnulf H ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Adenocarcinoma; Esophageal cancer; Lymph node metastases; Neoadjuvant therapy; Squamous cell carcinoma; TNM classification

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CORRELATION COEFFICIENT; DIAGNOSTIC VALUE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MULTIVARIATE ANALYSIS; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR LENGTH; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL COUNT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 33749041913     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20569     Document Type: Article

References (38)

1. Gospodarowicz MK, Henson DE, Hutter RVP, et al.: editors. "Prognostic factors in cancer" Second edition. New York: Wiley-Liss, 2001.
2. Wittekind C, Greene FL, Henson DE, et al.: editors. "TNM-supplement - A commentary on uniform use". Third edition. New York: Wiley-Liss, 2003.
3. Bollschweiler E, Schneider P, Monig S, et al.: Prognostic relevance of biological and molecular markers in oncology. Criteria for planning and interpreting studies. Chirurg 2003;74:139-144.
4. Lerut T, Coosemans W, Decker G, et al.: Extended surgery for cancer of the esophagus and gastroesophageal junction. J Surg Res 2004;117:58-63.
5. Tabira Y, Yasunaga M, Nakano K, et al.: All pathological T4 esophageal carcinomas should be categorized as stage IV. Hepatogastroenterology 2002;49:694-698.
6. Eloubeidi M, Desmond R, Arguedas M, et al.: Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: The importance of tumor length and lymph node status. Cancer 2002;95:1434-1443.
7. Roder J, Busch R, Stein H, et al.: Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 1994;81:410-413.
8. Tachibana M, Dhar D, Kinugasa S, et al.: Esophageal cancer with distant lymph node metastasis: Prognostic significance of metastatic lymph node ratio. J Clin Gastroenterol 2000;31:318-322.
9. Sobin LH, Wittekind C, editors. "TNM classification of malignant tumors, 6th edition". New York: John Wiley&Sons, 2002.
10. Hölscher A, Schroder W, Bollschweiler E, et al.: How safe is high intrathoracic esophagogastrostomy? Chirurg 2003;74:726-733.
11. Warnecke-Eberz U, Metzger R, Miyazono F, et al.: High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer. Clin Cancer Res 2004;10:3794-3799.
12. Schneider P, Baldus S, Metzger R, et al.: Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: Implications for response classification. Ann Surg 2005;242:684-692.
13. Bollschweiler E: Benefits and limitations of Kaplan-Meier calculations of survival chance in cancer surgery. Langenbecks Arch Surg 2003;388:239-244.
14. LeBlanc M: Tree-based methods for prognostic stratification. In: Crowley J, editor. Handbook of statistics in clinical oncology 2001. Marcel Decker, New York: Basel. 457-471.
15. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Statist Asoc 1958;53:457-481.
16. Pocock SJ, Clayton TC, Altman DG: Survival plots of time-to-event outcomes in clinical trials: Good practice and pitfalls. Lancet 2002;359:1686-1689.
17. Denoix P, Schwartz D: Règles générale de classification des cancers et de présentation des résultats thérapeutique. Academie de Chirurgie (Paris) 1959;85:415-424.
18. Sobin L: TNM: Evolution and relation to other prognostic factors. Semin Surg Oncol 2003;21:3-7.
19. Baba M, Aikou T, Natsugoe S, et al.: Lymph node and perinodal tissue tumor involvement in patients with esophagectomy and three-field lymphadenectomy for carcinoma of the esophagus. J Surg Oncol 1997;64:12-16.
20. Baba M, Aikou T, Yoshinaka H, et al.: Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg 1994;219:310-316.
21. Hölscher A, Bollschweiler E, Bumm R, et al.: Prognostic factors of resected adenocarcinoma of the esophagus. Surgery 1995;118: 845-855.
22. Siewert J, Stein H: Lymph-node dissection in squamous cell esophageal cancer - who benefits? Langenbecks Arch Surg 1999;384:141-148.
23. Korst R, Rusch V, Venkatraman E, et al.: Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 1998;115:660-669; discussion 69-70.
24. Swanson S, Batirel H, Bueno R, et al.: Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma. Ann Thorac Surg 2001;72:1918-1924; discussion 24-25.
25. Wang L, Chow K, Chi K, et al.: Prognosis of esophageal squamous cell carcinoma: Analysis of clinicopathological and biological factors. Am J Gastroenterol 1999;94:1933-1940.
26. Nigro J, Hagen J, DeMeester MT, et al.: Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: Implications for therapy. J Thorac Cardiovasc Surg 1999;117:16-23; discussion 23-25.
27. Becker K, Mueller J, Schulmacher C, et al.: Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 2003;98:1521-1530.
28. Natsugoe S, Matsumoto M, Nakashima S, et al.: Effect of neoadjuvant chemotherapy for lymph node micrometastasis and tumor cell microinvolvement in the patients with esophageal carcinoma. Cancer Lett 2000;159:119-125.
29. Ellis F, Heatley G, Balogh K: Proposal for improved staging criteria for carcinoma of the esophagus and cardia. Eur J Cardiothorac Surg 1997;12:361-364; discussion 364-365.
30. Nishimaki T, Suzuki T, Suzuki S, et al.: Outcomes of extended radical esophagectomy for thoracic esophageal cancer. J Am Coll Surg 1998;186:306-312.
31. Tabira Y, Lida S, Ichimaru T, et al.: Is upper mediastinal lymphadenectomy necessary in squamous carcinoma of the lower thoracic oesophagus? Int Surg 2000;85:277-280.
32. Hsu C, Chen C, Hsia J, et al.: Prediction of prognosis by the extent of lymph node involvement in squamous cell carcinoma of the thoracic esophagus. Eur J Cardiothorac Surg 2001;19:10-13.
33. Hagen J, De MS, Peters J, et al.: Curative resection for esophageal adenocarcinoma: Analysis of 100 en bloc esophagectomies. Ann Surg 2001;234:520-530; discussion 530-531.
34. Igaki H, Kato H, Tachimori Y, et al.: Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissection. Surgery 2003;133:368-374.
35. de Manzoni G, Pedrazzani C, Verlato G, et al.: Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction. Br J Surg 2004;91:296-303.
36. Kunisaki C, Akiyama H, Nomura M, et al.: Developing an appropriate staging system for esophageal carcinoma. J Am Coll Surg 2005;201:884-890.
37. Saha S, Dehn T: Ratio of invaded to removed lymph nodes as a prognostic factor in adenocarcinoma of the distal esophagus and esophagogastric junction. Dis Esophagus 2001;14:32-36.
38. van Sandick J, van Lanschot J, ten Kate F, et al.: Indicators of prognosis after transhiatal esophageal resection without thoracotomy for cancer. J Am Coll Surg 2002;194:28-36.